vatalanib has been researched along with Niemann-Pick Disease, Type C in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, JH; Bae, JS; He, X; Hong, YR; Jin, HK; Kim, H; Lee, H; Lee, JK; Marti, HH; Okada, Y; Okino, N; Otsu, M; Park, JH; Park, MH; Schuchman, EH; Seo, EJ | 1 |
1 other study(ies) available for vatalanib and Niemann-Pick Disease, Type C
| Article | Year |
|---|---|
Pathological roles of the VEGF/SphK pathway in Niemann-Pick type C neurons.
Topics: Adaptor Proteins, Signal Transducing; Animals; Autophagy; Bone Marrow Cells; Carrier Proteins; Cell Line; Humans; Induced Pluripotent Stem Cells; Intracellular Signaling Peptides and Proteins; Male; Membrane Glycoproteins; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, SCID; Mice, Transgenic; Microspheres; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Phthalazines; Protein Kinase Inhibitors; Purkinje Cells; Pyridines; RNA Interference; RNA, Small Interfering; Sphingosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2014 |